Skip to Main Content

Paper Details

Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer.
Breast Cancer Research and Treatment
6
2021
AKT, CDK4/6is, ER, ER+, Estrogen, Estrogen receptor, HER2, HR, HR+/HER2- mBC, cyclin-dependent kinase 4/6, hormone receptor, hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer, human epidermal growth factor 2, mBC, mBCs, mammalian target, metastatic breast cancers, phosphatidylinositol, phosphatidylinositol 3'-kinase, rapamycin, tumors
Author NameAffiliation
Charles Kent OsborneDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Mothaffar F RimawiDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
  • 1 - 2

Datasets

Release 1.2